Taiho Oncology Patient Assistance Program

Funded
About
The Taiho Oncology Patient Assistance Program offers invaluable support for patients in need of Taiho Oncology's medications, including Inqovi, Lonsurf, and Lytgobi. This program ensures that eligible patients who meet specific financial and medical criteria can receive their prescribed treatments at no cost, particularly aiding those with limited or no prescription insurance coverage. By facilitating access to necessary medications, the Taiho Oncology Patient Assistance Program plays a crucial role in patient care and treatment adherence.
Insurance requirements: Medicare / Medicaid, Underinsured, Uninsured
Enrollment Forms
Enrollment Form
Program Requirements
Valid only for residents in the US and Puerto Rico
Enrollment Required: Yes
Coverage Required: No
Needs Based: Yes
Activation Required: No
Program Details
Eligible patients may receive LONSURF at no cost based on assistance, financial, and medical criteria
Patient's doctor must fax completed enrollment form (patient must complete the second page) and prescription to: 18442872559
Underinsured/uninsured patients complete the same enrollment form as commercially insured patients
Eligibility for Medicare Part D patients expires at the end of the calendar year
Other Programs

Accessia Health: Myelodysplastic Syndromes - Private Insurance: Waitlist

Commercially Insured
Underinsured
Uninsured
Max Saving: $5500/year*

Accessia Health: Myelodysplastic Syndromes - Public Insurance: Waitlist

Medicare / Medicaid
Max Saving: $3500/year*
Other Tools for Inqovi